SHL Medical

SHL Medical is a world-leading designer, developer, and manufacturer of drug delivery solutions such as autoinjectors. The company was founded in 1989 and is headquartered in Switzerland. With a strong focus on its company purpose of Enabling Patients’ Independence, SHL Medical partners with leading pharma and biotech companies to pioneer the development of patient-centric solutions that support the enhancement of patients' quality of life through self-injection systems and digital healthcare solutions.

With over 5,000 employees located across its Switzerland, USA, Sweden, and Taiwan offices, SHL Medical relies on its comprehensive in-house manufacturing capabilities to provide end-to-end services, from design and development to final assembly, labeling, and packaging. The latest investment in the company occurred on the 09 December 2022 through a Secondary Market investment by EQT.

SHL Medical operates within the manufacturing industry and continues to make strides in advancing drug delivery systems, particularly autoinjectors, to improve patients' lives and healthcare experiences.